ACP launches study of cloud-based quality improvement program on diabetes and CVD care

February 14, 2013

PHILADELPHIA, February 14, 2013 -- The American College of Physicians (ACP) in collaboration with CECity, developer of MedConcert®, a social cloud-based performance improvement platform, will pilot and test the impact of a technology-based quality improvement program on physician participation, value to practices, rapid-cycle learning, and patient outcomes.

The one-year pilot program, "Improving the Quality of Diabetes Care," will tailor MedConcert with diabetes and cardiovascular disease prevention content. More than 11 percent of adults in the United States - an estimated 26 million people - have diabetes, which is associated with multiple complications and co-morbid conditions, including cardiovascular disease.

"This initiative will provide important data to help us determine the feasibility of recruiting physician offices to participate in an integrated, technology-based quality improvement program and assess facilitators and barriers," said Michael S. Barr, MD, MBA, FACP, who leads ACP's Medical Practice, Professionalism & Quality division. "The data also will enable us to assess the ease of adopting this type of technology into the workflows of physician practices and whether it correlates with improved care processes, patient satisfaction, and patient outcomes."

Up to 50 internal medicine practices in three states in the pilot will have access to the following web-based tools:Physicians may access MedConcert's secure social networks to engage in peer-to-peer clinical communities that enable patient coordination of care and real-time communications for sharing best practices. MedConcert also houses a library of diabetes and CVD resources and educational materials, including patient education tools, linked to specific gaps in performance identified in the registry data, which are also available to participants.

A report on the results of the pilot quality improvement program is expected by the end of the year. The Center for Health Services and Outcomes Research at Johns Hopkins University's Bloomberg School of Public Health will conduct the program evaluation.
-end-
About the American College of Physicians

The American College of Physicians is the largest medical specialty organization and the second-largest physician group in the United States. ACP members include 133,000 internal medicine physicians (internists), related subspecialists, and medical students. Internal medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness. Follow ACP on Twitter and Facebook.

About CECity

Founded in 1997, Pittsburgh, Pennsylvania-based CECity is the health care industry's leading software as a service (SaaS) provider of cloud-based applications and distribution networks for Performance Improvement and Lifelong Learning. Health care professionals and organizations, including quality organizations, health plans, hospitals, pharmacy chains, certifying boards, licensing boards, publishers, professional societies, academic medical centers and educational providers, count on CECity to power their solutions for continuous performance improvement, registries, professional development, patient safety and adherence, population health informatics and quality reporting in support of health care and payment reform.

MedConcert, powered by CECity, represents the health care industry's first multi-tenant cloud-based platform that is designed to connect stakeholders in a meaningful way to bridge the "House of Medicine" and the "Practice of Medicine" to drive continuous performance improvement, coordination of care, and lifelong learning. MedConcert is a real world implementation of the Learning Health System, which has been proposed by CMS, IOM and others as a critical component of driving quality and improving patient care.

American College of Physicians

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.